BioMADE announced 17 innovative new projects that will drive the scale-up and commercialization of American biomanufactured products. They include producing biodegradable plastics; upcycling waste to create new products; certification programs to prepare the workforce of tomorrow’s U.S. bioeconomy; developing cell-free systems for commodity chemicals; and more.
These projects highlight the breadth and depth of BioMADE’s membership, representing 30 member organizations—spanning 18 states from New York to Texas—throughout the private and nonprofit sectors, academic research institutions, and community colleges. This work will revitalize American manufacturing by advancing and commercializing the bioindustrial production of components incorporated into everyday items; reshoring manufacturing jobs; and bolstering a domestic supply chain of commodity and platform chemicals. This announcement embodies BioMADE’s mission of supporting projects that will enhance competitiveness of the U.S. bioindustrial manufacturing industry.
“America’s leadership in research must be matched by leadership in process and scale-up capability. That is what today’s biomanufacturing announcement is all about,” said Assistant to the President for Science and Technology and Director of the White House Office of Science and Technology Policy Arati Prabhakar. “That’s how the vision of engineering living cells to sustainably produce chemicals, materials, and structures will become a reality. Thanks to the leadership of President Biden and Vice President Harris, we can lead the world in biomanufacturing.”
“The next five to ten years will determine the global leader of the bioeconomy. At BioMADE, we believe the U.S. is uniquely positioned to seize this opportunity,” said Dr. Douglas Friedman, Chief Executive Officer at BioMADE. “We are proud to support these member-driven projects that will translate our country’s rich history of biotechnology innovation into manufacturing leadership. All Americans will benefit from investments in America’s bioindustrial manufacturing future.”